Rare solid tumours as indicators of hereditary cancer syndromes.
Certain rare tumors can be red flags for hereditary cancer syndromes, helping doctors identify families who benefit from genetic testing and preventive screening.
This review from EJHG maps rare solid tumour types that strongly indicate underlying hereditary cancer syndromes, serving as clinical flags for genetic testing. The work is directly relevant to improving rare disease diagnosis and cascade screening.
What the study was
- Study design
- Narrative review
- Population
- Patients with rare solid tumours
- Category
- Genomics/Precision Medicine
- Maturity
- Validated
- Journal
- European Journal of Human Genetics
Why it surfaced
Clinical review linking rare tumours to hereditary cancer syndromes. High unmet need for rare disease patients. Foulkes WD is a top cancer genetics authority.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.